Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C

Reona Morio(Hiroshima University), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Tomoki Kobayashi(Hiroshima University), Akira Hiramatsu(Hiroshima University), C. Nelson Hayes(Hiroshima University), Michio Imamura(Hiroshima University), Keiji Tsuji(Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital), Masataka Tsuge(Hiroshima University), Tomokazu Kawaoka(Hiroshima University), Hiroshi Aikata(Hiroshima Prefectural Hospital), Daiki Miki(Hiroshima University), Kei Morio(Hiroshima University), Satoe Yokoyama(Hiroshima University), Nami Mori(Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital), Shoichi Takahashi(Hiroshima University), Hidenori Ochi(Hiroshima University), Shintaro Takaki(Frontier Science Foundation), Yuko Nagaoki(Hiroshima University), Yoshiiku Kawakami(Hiroshima University Hospital), Yuki Kimura(Jichi Medical University)
Journal of Gastroenterology
September 8, 2016
Cited by 20


Related Papers